Literature DB >> 22581304

The effect of biomaterials and antifungals on biofilm formation by Candida species: a review.

M Cuéllar-Cruz1, A Vega-González, B Mendoza-Novelo, E López-Romero, E Ruiz-Baca, M A Quintanar-Escorza, J C Villagómez-Castro.   

Abstract

Candida albicans, C. glabrata, C. parapsilosis, and C. tropicalis are able to form biofilms on virtually any biomaterial implanted in a human host. Biofilms are a primary cause of mortality in immunocompromised and hospitalized patients, as they cause recurrent and invasive candidiasis, which is difficult to eradicate. This is due to the fact that the biofilm cells show high resistance to antifungal treatments and the host defense mechanisms, and exhibit an excellent ability to adhere to biomaterials. Elucidation of the mechanisms of antifungal resistance in Candida biofilms is of unquestionable importance; therefore, this review analyzes both the chemical composition of biomaterials used to fabricate the medical devices, as well as the Candida genes and proteins that confer drug resistance.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22581304     DOI: 10.1007/s10096-012-1634-6

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  160 in total

1.  Direct characterization of the physicochemical properties of fungal spores using functionalized AFM probes.

Authors:  Y F Dufrêne
Journal:  Biophys J       Date:  2000-06       Impact factor: 4.033

2.  An unscaled parameter to measure the order of surfaces: a new surface elaboration to increase cells adhesion.

Authors:  M Bigerelle; K Anselme; E Dufresne; P Hardouin; A Iost
Journal:  Biomol Eng       Date:  2002-08

3.  Biofilm formation by five species of Candida on three clinical materials.

Authors:  D Estivill; A Arias; A Torres-Lana; A J Carrillo-Muñoz; M P Arévalo
Journal:  J Microbiol Methods       Date:  2011-06-12       Impact factor: 2.363

4.  Contribution of mutations in the cytochrome P450 14alpha-demethylase (Erg11p, Cyp51p) to azole resistance in Candida albicans.

Authors:  Patrick Marichal; Luc Koymans; Staf Willemsens; Danny Bellens; Peter Verhasselt; Walter Luyten; Marcel Borgers; Frans C S Ramaekers; Frank C Odds; Hugo Vanden Bossche
Journal:  Microbiology       Date:  1999-10       Impact factor: 2.777

5.  Coating of a surface with 2-methacryloyloxyethyl phosphorylcholine (MPC) co-polymer significantly reduces retention of human pathogenic microorganisms.

Authors:  Katsuhiko Hirota; Keiji Murakami; Ken Nemoto; Yoichiro Miyake
Journal:  FEMS Microbiol Lett       Date:  2005-07-01       Impact factor: 2.742

6.  Candidemia in a tertiary care hospital: epidemiology and factors influencing mortality.

Authors:  H Alonso-Valle; O Acha; J D García-Palomo; C Fariñas-Alvarez; C Fernández-Mazarrasa; M C Fariñas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-03-22       Impact factor: 3.267

7.  Influence of hyaluronic acid on bacterial and fungal species, including clinically relevant opportunistic pathogens.

Authors:  Andrea Ardizzoni; Rachele G Neglia; Maria C Baschieri; Claudio Cermelli; Manuela Caratozzolo; Elena Righi; Beniamino Palmieri; Elisabetta Blasi
Journal:  J Mater Sci Mater Med       Date:  2011-09-04       Impact factor: 3.896

8.  A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients.

Authors:  Peter G Pappas; John H Rex; Jeannette Lee; Richard J Hamill; Robert A Larsen; William Powderly; Carol A Kauffman; Newton Hyslop; Julie E Mangino; Stanley Chapman; Harold W Horowitz; John E Edwards; William E Dismukes
Journal:  Clin Infect Dis       Date:  2003-08-14       Impact factor: 9.079

9.  Comparison of results of fluconazole and voriconazole disk diffusion testing for Candida spp. with results from a central reference laboratory in the ARTEMIS DISK Global Antifungal Surveillance Program.

Authors:  Michael A Pfaller; Linda Boyken; Richard J Hollis; Jennifer Kroeger; Shawn A Messer; Shailesh Tendolkar; Daniel J Diekema
Journal:  Diagn Microbiol Infect Dis       Date:  2009-09       Impact factor: 2.803

10.  Candida biofilms and the host: models and new concepts for eradication.

Authors:  Hélène Tournu; Patrick Van Dijck
Journal:  Int J Microbiol       Date:  2011-11-14
View more
  15 in total

1.  Anti-biofilm properties of eucalyptol in combination with antifungals against Candida albicans isolates in patients with hematological malignancy.

Authors:  Mahyar Keymaram; Mehraban Falahati; Shirin Farahyar; Ensieh Lotfali; Sara Abolghasemi; Shahram Mahmoudi; Fatemeh Sadeghi; Halala Khalandi; Reza Ghasemi; Sina Shamsaei; Omid Raiesi
Journal:  Arch Microbiol       Date:  2022-05-04       Impact factor: 2.552

2.  Comparative Study of the Effects of Fluconazole and Voriconazole on Candida glabrata, Candida parapsilosis and Candida rugosa Biofilms.

Authors:  Priya Madhavan; Farida Jamal; Chong Pei Pei; Fauziah Othman; Arunkumar Karunanidhi; Kee Peng Ng
Journal:  Mycopathologia       Date:  2018-01-29       Impact factor: 2.574

3.  Identification of genes upregulated by the transcription factor Bcr1 that are involved in impermeability, impenetrability, and drug resistance of Candida albicans a/α biofilms.

Authors:  Thyagarajan Srikantha; Karla J Daniels; Claude Pujol; Elena Kim; David R Soll
Journal:  Eukaryot Cell       Date:  2013-04-05

4.  Inhibitory Effect of 5-Aminoimidazole-4-Carbohydrazonamides Derivatives Against Candida spp. Biofilm on Nanohydroxyapatite Substrate.

Authors:  C Gabriel; L Grenho; F Cerqueira; R Medeiros; A M Dias; A I Ribeiro; M F Proença; M H Fernandes; J C Sousa; F J Monteiro; M P Ferraz
Journal:  Mycopathologia       Date:  2019-11-02       Impact factor: 2.574

5.  Antimicrobial and Antibiofilm Activity of Chitosan on the Oral Pathogen Candida albicans.

Authors:  Eduardo Costa; Sara Silva; Freni Tavaria; Manuela Pintado
Journal:  Pathogens       Date:  2014-12-11

6.  Adhesion, biofilm formation, cell surface hydrophobicity, and antifungal planktonic susceptibility: relationship among Candida spp.

Authors:  Ana Silva-Dias; Isabel M Miranda; Joana Branco; Matilde Monteiro-Soares; Cidália Pina-Vaz; Acácio G Rodrigues
Journal:  Front Microbiol       Date:  2015-03-12       Impact factor: 5.640

7.  Ultrastructural analysis of Candida albicans when exposed to silver nanoparticles.

Authors:  Roberto Vazquez-Muñoz; Miguel Avalos-Borja; Ernestina Castro-Longoria
Journal:  PLoS One       Date:  2014-10-07       Impact factor: 3.240

Review 8.  Biomaterials for the Prevention of Oral Candidiasis Development.

Authors:  Dan Cristian Gheorghe; Adelina-Gabriela Niculescu; Alexandra Cătălina Bîrcă; Alexandru Mihai Grumezescu
Journal:  Pharmaceutics       Date:  2021-05-27       Impact factor: 6.321

9.  Bioactive Coatings with Ag-Camphorimine Complexes to Prevent Surface Colonization by the Pathogenic Yeast Candida albicans.

Authors:  M Joana F Pinheiro; Joana P Costa; Fernanda Marques; Nuno P Mira; M Fernanda N N Carvalho; Marta M Alves
Journal:  Antibiotics (Basel)       Date:  2021-05-26

Review 10.  Potential Use of Phenolic Acids as Anti-Candida Agents: A Review.

Authors:  Guilherme R Teodoro; Kassapa Ellepola; Chaminda J Seneviratne; Cristiane Y Koga-Ito
Journal:  Front Microbiol       Date:  2015-12-21       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.